This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Curious about LyondellBasell (LYB) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for LyondellBasell (LYB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
LYBPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Equity Residential (EQR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Equity Residential (EQR) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
EQRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about Masco (MAS) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Masco (MAS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
MASPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Biogen (BIIB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
BIIBPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of ON Semiconductor Corp. (ON) Q2 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for ON Semiconductor Corp. (ON), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
ONPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
QUBT or RGTI: Which Quantum Stock Offers the Better Upside Now?
by Urmimala Biswas
QUBT and RGTI are racing toward quantum profits- but only one boasts real revenues, a clear roadmap and major government backing.
QUBTNegative Net Change RGTINegative Net Change
cloud-computing computers earnings-preview tech-stocks
Should You Buy, Sell, or Hold Innodata Stock Before Q2 Earnings?
by Nilanshi Mukherjee
INOD's second-quarter performance is expected to have benefited from Gen AI momentum and key customer expansion.
CTSHPositive Net Change INFYPositive Net Change EXLSPositive Net Change INODPositive Net Change
artificial-intelligence earnings-outlook earnings-preview earnings-report tech-stocks
Reddit Stock Before Q2 Earnings: Hold or Fold the Stock?
by Kashvi Chandgothia
RDDT's Q2 earnings may reflect continued advertising momentum, though stretched valuation and macroeconomic uncertainty are challenges.
MSFTPositive Net Change GOOGLPositive Net Change METAPositive Net Change RDDTPositive Net Change
ad-tech advertising artificial-intelligence earnings-preview reddit-stocks tech-stocks
Mastercard Q2 Earnings Incoming: Hold the Card or Fold the Hand?
by Kaibalya Pravo Dey
MA eyes a Q2 earnings beat with strong cross-border volumes and rising demand for services, despite higher costs.
MAPositive Net Change VPositive Net Change AXPPositive Net Change
business-services earnings-outlook earnings-preview finance payments
Howmet Q2 Earnings Preview: Should You Buy the Stock Now or Wait?
by Avisekh Bhattacharjee
HWM's Q2 gains in aerospace are likely to have been tempered by supply-chain woes and transportation softness-should investors wait?
BAPositive Net Change GDPositive Net Change HWMPositive Net Change RTXPositive Net Change
aerospace earnings-preview
Camtek (CAMT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Camtek (CAMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CAMTPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Celsius Holdings Inc. (CELH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celsius (CELH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CELHPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Carlyle Secured Lending, Inc. (CGBD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Carlyle Secured Lending (CGBD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CGBDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Clearway Energy (CWEN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Clearway Energy (CWEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CWENNegative Net Change CRGYPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Ball (BALL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ball (BALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BALLPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
BridgeBio Pharma (BBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BBIOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Will Beam Therapeutics Inc. (BEAM) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Beam Therapeutics (BEAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BEAMPositive Net Change CRSPPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
The Baldwin Insurance Group (BWIN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Baldwin Insurance Group (BWIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BWINPositive Net Change RGAPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Arista Networks (ANET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arista Networks (ANET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ANETPositive Net Change PCORPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ANIPPositive Net Change BMRNPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Angel Oak Mortgage (AOMR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Angel Oak (AOMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AOMRNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ardent Health, Inc. (ARDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ARDTNo Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AXGNPositive Net Change IDXXPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
AdaptHealth Corp. (AHCO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
AdaptHealth (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AHCOPositive Net Change NVSTPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Alight, Inc. (ALIT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Alight (ALIT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALITPositive Net Change APPFNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate